Total Payments
$4,536
2024 Payments
$953.35
Companies
21
Transactions
49
Medicare Patients
963
Medicare Billing
$102,469
Payment Breakdown by Category
Food & Beverage$4,495 (99.1%)
Other$41.22 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,495 | 47 | 99.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41.22 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $831.71 | 6 | $0 (2024) |
| SK Life Science, Inc. | $454.80 | 4 | $0 (2024) |
| EMD Serono, Inc. | $369.28 | 5 | $0 (2019) |
| Amgen Inc. | $311.60 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $253.21 | 4 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $241.20 | 2 | $0 (2019) |
| Celgene Corporation | $233.09 | 2 | $0 (2024) |
| Neurelis, Inc. | $215.78 | 2 | $0 (2024) |
| Lilly USA, LLC | $205.61 | 3 | $0 (2024) |
| Biogen, Inc. | $204.94 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $953.35 | 9 | JAZZ PHARMACEUTICALS INC. ($141.39) |
| 2023 | $747.94 | 6 | JAZZ PHARMACEUTICALS INC. ($424.34) |
| 2022 | $451.37 | 4 | JAZZ PHARMACEUTICALS INC. ($265.98) |
| 2021 | $617.01 | 6 | SK Life Science, Inc. ($206.10) |
| 2020 | $92.64 | 1 | Novartis Pharmaceuticals Corporation ($92.64) |
| 2019 | $1,227 | 15 | EMD Serono, Inc. ($369.28) |
| 2018 | $298.12 | 3 | Sunovion Pharmaceuticals Inc. ($118.20) |
| 2017 | $148.95 | 5 | Acorda Therapeutics, Inc ($112.33) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $120.60 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $105.31 | General |
| Category: EPILEPSY | ||||||
| 10/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $108.32 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $120.31 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $121.61 | General |
| Category: Immunology | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Neurology | ||||||
| 06/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $141.39 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $95.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/25/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/19/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $99.80 | General |
| Category: Neurology | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $118.66 | General |
| Category: Rare Disease | ||||||
| 10/20/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $146.05 | General |
| Category: NEUROLOGY | ||||||
| 07/19/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $146.62 | General |
| Category: NEUROLOGY | ||||||
| 06/27/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $105.14 | General |
| Category: Neurology | ||||||
| 05/01/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $131.67 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $61.24 | General |
| Category: Migraine | ||||||
| 08/30/2022 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $131.16 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2022 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: Neurology | ||||||
| 04/19/2022 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $134.82 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $118.58 | General |
| Category: Neurology | ||||||
| 07/27/2021 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $82.92 | General |
| 07/20/2021 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $92.75 | General |
| 03/30/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.77 | General |
| Category: Neuroscience | ||||||
| 02/23/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $87.52 | General |
| Category: Neurology | ||||||
| 01/19/2021 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $110.47 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 249 | 301 | $107,527 | $26,616 |
| 2022 | 9 | 260 | 356 | $109,802 | $26,985 |
| 2021 | 7 | 233 | 290 | $95,413 | $24,882 |
| 2020 | 6 | 221 | 282 | $95,258 | $23,985 |
Total Patients
963
Total Services
1,229
Medicare Billing
$102,469
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 57 | $34,029 | $7,388 | 21.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 114 | $24,396 | $6,780 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 46 | $14,122 | $4,043 | 28.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $12,896 | $3,120 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $11,940 | $2,564 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $6,460 | $1,836 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $3,684 | $884.40 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 117 | $25,038 | $6,344 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 40 | $23,880 | $5,734 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 40 | $16,120 | $3,845 | 23.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 48 | $14,736 | $3,718 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $7,106 | $2,151 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $9,552 | $1,881 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 21 | $6,447 | $1,558 | 24.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 18 | 19 | $4,085 | $967.23 | 23.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 14 | 33 | $2,838 | $789.07 | 27.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 55 | 55 | $32,835 | $8,269 | 25.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 77 | 127 | $27,178 | $7,013 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 37 | 37 | $14,911 | $3,924 | 26.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 22 | 22 | $7,106 | $2,180 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 19 | $5,833 | $1,551 | 26.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 14 | 19 | $4,085 | $1,051 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 11 | $3,465 | $893.97 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 76 | 134 | $28,676 | $7,465 | 26.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 38 | $22,686 | $5,938 | 26.2% |
About Dr. Aleksey Androsov, M.D
Dr. Aleksey Androsov, M.D is a Neurology healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1104258144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aleksey Androsov, M.D has received a total of $4,536 in payments from pharmaceutical and medical device companies, with $953.35 received in 2024. These payments were reported across 49 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,495).
As a Medicare-enrolled provider, Androsov has provided services to 963 Medicare beneficiaries, totaling 1,229 services with total Medicare billing of $102,469. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cape Girardeau, MO
- Active Since 08/01/2013
- Last Updated 03/22/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104258144
Products in Payments
- EPIDIOLEX (Drug) $831.71
- XCOPRI (Drug) $454.80
- Mavenclad (Biological) $243.42
- APTIOM (Drug) $241.20
- ZEPOSIA (Drug) $233.09
- VALTOCO (Drug) $215.78
- Repatha (Biological) $186.83
- GILENYA (Drug) $160.57
- Aimovig (Biological) $124.77
- OCREVUS (Biological) $123.95
- BRIUMVI (Drug) $121.61
- Leqembi (Drug) $120.60
- KISUNLA (Drug) $120.31
- ANDEXXA (Biological) $118.66
- AMPYRA (Drug) $112.33
- NUPLAZID (Drug) $111.26
- TYSABRI (Biological) $105.14
- VUMERITY (Drug) $99.80
- MAYZENT (Drug) $92.64
- Briviact (Drug) $89.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cape Girardeau
Robert Gardner, Md, MD
Neurology — Payments: $103,392
Neurology $103,392
David Lee, Md, MD
Neurology — Payments: $23,480
Neurology $23,480
Dr. Randall Stahly, D.o, D.O
Neurology — Payments: $8,008
Neurology $8,008
James Laguardia, M.d, M.D
Neurology — Payments: $4,860
Neurology $4,860
Dr. Mark Farrenburg, M.d, M.D
Neurology — Payments: $2,221
Neurology $2,221
Richard Ronca
Neurology — Payments: $413.49
Neurology $413.49